HeraMED (ASX:HMD) Buyback Yield %: -3.97 (As of Jul. 05, 2026)


What is HeraMED Buyback Yield %?

HeraMED ASX:HMD +2.38% Buyback Yield % is -3.97 as of Jul. 05, 2026. The stock has 1 warning sign investors should review. Among 347 Medical Devices & Instruments companies, HeraMED ranks worse than 61.96% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

HeraMED's current buyback yield was -3.97%.

HeraMED Buyback Yield % Historical Data

* Premium members only.

The historical data trend for HeraMED's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HeraMED Buyback Yield % Chart

HeraMED Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Buyback Yield %
Get a 7-Day Free Trial -10.12 -12.80 -40.37 -40.45 -5.14

HeraMED Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -40.37 -5.24 -40.45 -100.45 -5.14

ASX:HMD vs ABT, SYK, MDT: Buyback Yield % Comparison

For the Medical Devices subindustry, HeraMED's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

HeraMED Buyback Yield % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, HeraMED's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where HeraMED's Buyback Yield % falls into.


HeraMED Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

HeraMED's Buyback Yield for the fiscal year that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 1.979) / 38.527308
=-5.14%

HeraMED's annualized Buyback Yield for the quarter that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 1.979) / 38.527308
=-5.14%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of -3.97 mean?
HeraMED (ASX:HMD) has a Buyback Yield % of -3.97 as of Jul. 05, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on HeraMED and its competitors. According to the industry distribution chart, HeraMED ranks #215 out of 347 companies in the Medical Devices & Instruments industry, placing it in the top 62%.
Is HeraMED's Buyback Yield % too high?
HeraMED's current Buyback Yield % is -3.97. Based on the distribution chart, HeraMED ranks #215 out of 347 companies in the Medical Devices & Instruments industry, which is below the industry midpoint.
How does HeraMED's Buyback Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, HeraMED ranks #215 out of 347 companies for Buyback Yield %. This places HeraMED in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Medical Devices & Instruments company?
A good Buyback Yield % depends on the Medical Devices & Instruments industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on HeraMED and its competitors. HeraMED's current Buyback Yield % is -3.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HeraMED stock overvalued right now?
Based on GuruFocus' analysis, HeraMED (ASX:HMD) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.02, compared to a current price of A$0.04 — trading 115% above its estimated fair value. The current Buyback Yield % is -3.97. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For HeraMED (ASX:HMD), the current Buyback Yield % is -3.97 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

HeraMED Business Description

Other Exchanges 1I4:Germany
Address 117 Camberwell Road, Level 1 - Suite 1, Hawthorn East, Melbourne, VIC, AUS, 3123
HeraMED Ltd is a medical data and technology company providing the digital transformation of maternity care by revolutionizing the prenatal and postpartum experience with its hybrid maternity care platform. It offers a proprietary platform that utilizes hardware and software to reshape the Doctor/Patient relationship using its clinically validated in-home foetal and maternal heart rate monitor, HeraBEAT, cloud computing, artificial intelligence. Its offering, HeraCARE, has been engineered to offer a fully integrated maternal health ecosystem designed to deliver care at a lower cost, ensure expectant mothers are engaged, informed and well-supported, and allow healthcare professionals to provide the care and enable early detection and prevention of potential risks.